We are live on
!
Find out more
AGM
Alpine Global Management Portfolio holdings
AUM
$668M
1-Year Est. Return
20.22%
This Fund
S&P 500
This Quarter
Est. Return
+14.93%
1 Year Est. Return
+20.22%
3 Year Est. Return
+100.14%
5 Year Est. Return
+103.13%
10 Year Est. Return
+677.44%
AUM
$301M
AUM Growth
-$127M
(-30%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-44.67%
Top 10 Holdings %
Top 10 Hldgs %
57.1%
Holding
842
New
352
Increased
28
Reduced
90
Closed
287
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$15.1M |
| 2 |
MYOV
Myovant Sciences Ltd.
MYOV
|
+$14.1M |
| 3 |
Cornerstone Strategic Value Fund
CLM
|
+$9.51M |
| 4 |
Albertsons Companies
ACI
|
+$3.96M |
| 5 |
Rivian
RIVN
|
+$3.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$56.5M |
| 2 |
Immunovant
IMVT
|
+$35.9M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$11.3M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$10.7M |
| 5 |
VMW
VMware, Inc
VMW
|
+$10M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.53% |
| 2 | Technology | 13.41% |
| 3 | Financials | 12.89% |
| 4 | Consumer Discretionary | 7.02% |
| 5 | Industrials | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Carvana
CVNA
$47.5B
| $127K | 0.04% |
+134,020
| New | +$283K |
|
127
Rackspace Technology
RXT
$960M
| $126K | 0.04% |
+42,563
| New | +$180K |
|
|
ENFN
128
DELISTED
Enfusion, Inc.
ENFN
| $126K | 0.04% |
+13,066
| New | +$147K |
|
129
Affirm
AFRM
$23.5B
| $124K | 0.04% |
+12,800
| New | +$193K |
|
130
Sprinklr
CXM
$1.51B
| $124K | 0.04% |
+15,185
| New | +$131K |
|
131
FuelCell Energy
FCEL
$1.45B
| $124K | 0.04% |
+1,488
| New | +$143K |
|
132
Nektar Therapeutics
NKTR
$2.39B
| $124K | 0.04% |
+3,671
| New | +$178K |
|
133
ACV Auctions
ACVA
$1.41B
| $123K | 0.04% |
+14,981
| New | +$125K |
|
134
ChargePoint
CHPT
$134M
| $123K | 0.04% |
+644
| New | +$156K |
|
135
GrowGeneration
GRWG
$84.7M
| $123K | 0.04% |
+31,397
| New | +$150K |
|
|
HPP
136
Hudson Pacific Properties
HPP
$758M
| $123K | 0.04% |
+1,810
| New | +$134K |
|
137
Rocket Lab Corp
RKLB
$36.6B
| $123K | 0.04% |
+32,500
| New | +$142K |
|
|
VXRT
138
DELISTED
Vaxart
VXRT
| $123K | 0.04% |
+128,354
| New | +$181K |
|
|
EXPR
139
DELISTED
Express, Inc.
EXPR
| $123K | 0.04% |
+6,016
| New | +$144K |
|
|
MNTV
140
DELISTED
Momentive Global Inc. Common Stock
MNTV
| $123K | 0.04% |
+17,636
| New | +$127K |
|
141
Adaptive Biotechnologies
ADPT
$3.61B
| $122K | 0.04% |
+16,008
| New | +$125K |
|
142
Marqeta
MQ
$1.93B
| $122K | 0.04% |
+4,984
| New | +$136K |
|
|
ONL
143
Orion Office REIT
ONL
$151M
| $122K | 0.04% |
+14,332
| New | +$131K |
|
144
Opendoor
OPEN
$3.54B
| $122K | 0.04% |
+108,989
| New | +$209K |
|
|
WE
145
DELISTED
WeWork Inc.
WE
| $122K | 0.04% |
+2,127
| New | +$199K |
|
146
CareDx
CDNA
$1.83B
| $121K | 0.04% |
+10,579
| New | +$157K |
|
147
Cerus
CERS
$575M
| $121K | 0.04% |
+33,139
| New | +$125K |
|
148
Compass
COMP
$8.67B
| $121K | 0.04% |
+51,915
| New | +$136K |
|
|
DADA
149
DELISTED
Dada Nexus
DADA
| $121K | 0.04% |
+17,424
| New | +$91.2K |
|
150
Nurix Therapeutics
NRIX
$2.45B
| $121K | 0.04% |
+10,989
| New | +$133K |
|
Similar funds
IACCIA
TAP
CWP
WSCM
AO
BCP
SP
LCM
Alpine Global Management's Q4 2022 Portfolio in Review
As of Q4 2022, Alpine Global Management held 842 positions worth $301M, down 30% from $427M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Alpine Global Management withdrew a net $134M in Q4 2022, closing 287 positions and reducing 90 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $56.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Technology and Financials.
Against the trend, Alpine Global Management opened a new position in Tesla worth $9.84M.
- Alpine Global Management's largest Q4 2022 buy was Tesla: 79,871 shares worth $9.84M.
- Alpine Global Management added most to Cornerstone Strategic Value Fund in Q4 2022, an estimated $9.51M increase.
- Alpine Global Management's biggest Q4 2022 reduction was Immunovant, cutting an estimated $35.9M.
- Alpine Global Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $56.5M.
- Alpine Global Management's ten largest holdings make up 57% of its $301M portfolio in Q4 2022.
- Alpine Global Management opened 352 new positions and closed 287 in Q4 2022.
- Alpine Global Management's portfolio value fell 30% quarter-over-quarter to $301M.
Based on Alpine Global Management's 13F filing for Q4 2022, filed 14 Feb 2023.